by Will Freyre | Nov 18, 2022 | Current
Teplizumab, the first drug that can delay the onset of type 1 diabetes, earns FDA approval after undergoing clinical trials at the Diabetes Research Institute The Diabetes Research Institute (DRI), one of the largest and most comprehensive research centers dedicated...
Recent Comments